Development of a Novel Screening Tool for Anosognosia After Stroke.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Exeter

About this trial

Anosognosia, a neurological inability to acknowledge or comprehend one's own (dis)abilities, is a multi-faceted phenomenon which has consistently gained traction in research fields spanning psychology, neurology, and cognition since its conceptual introduction in 1914. Though anosognosia is not limited to following only neurological disease or injury, the majority of research has focused on the prevalence and mechanisms of anosognosia after stroke. Despite this, there is no clear consensus among the literature, and thus in clinical practice, as to how anosognosia after stroke should be assessed. This is startling given the plethora of studies which highlight anosognosia as a barrier to rehabilitation, a risk to safe discharge, and a predictor of poorer psychological and functional outcomes for both patients and their carers. Currently, there exists a vast number of assessment methods for anosognosia after stroke, which vary from performance- and observation-based tasks to self-report and discrepancy-based interviews; clinicians working in stroke make arbitrary choices as to which of these methods to use on a case-by-case basis, risking missed cases and subsequently noncomprehensive care. This research aims to develop a new screening tool for anosognosia that can be routinely implemented with post-stroke patients in hospital settings, to inform care, rehabilitation, and discharge. The study will explore the acceptability and feasibility of the new screening tool among multi-disciplinary staff working on a stroke rehabilitation unit, and provide grounds for future studies to assess the screen's psychometric properties and ability to inform novel interventions for anosognosia. Findings will have great implications for stroke survivors, their carers, and healthcare professionals alike.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18 years or above who are admitted to the stroke rehabilitation unit with a clinical diagnosis of stroke.

Multi-disciplinary staff working on the stroke rehabilitation unit.

Disqualifiers

Patients with a clinical diagnosis other than stroke.

Trial population

Stroke patients admitted to a stroke rehabilitation ward. Multi-disciplinary staff working with stroke patients on a stroke rehabilitation ward.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

90 Participants
are grouped into 2 trial groups
Group A: Patients
Group B: Staff

Trial outcomes

Primary outcomes

1

Acceptability and Feasibility of new screening tool among multi-disciplinary staff

Focus groups will be conducted with staff who administer the new screening tool on the target stroke rehabilitation ward, to explore their views of and experiences with the tool. This will be in relation to the tool's content, structure, length, response/scoring formats, and administration demands.

Time frame
From recruitment, throughout 4-6 months of screen implementation, to the completion of focus groups approximately 8 months after recruitment.

Secondary outcomes

1

Uptake and Validity of new screening tool, with patients

Demographic data and stroke-related data (stroke location, severity) will provide descriptive insight into the usability of the tool across subgroups of the sample. Numbers of completed forms will provide descriptive insight into the uptake of the screening tool. Inter-rater reliability will provide insight into the tool's equivalence.

Time frame
Over 4-6 months, from recruitment until the completion of screen implementation.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Exeter

Lead sponsor

Royal Devon and Exeter NHS Foundation Trust

Collaborator

This trial is not recruiting at the moment. You can still explore other options: